D.E. Shaw & Co
RBOT

D.E. Shaw & Co’s Vicarious Surgical RBOT Stock Holding History

D.E. Shaw & Co’s Portfolio RBOT Stock Details RBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,188
Closed -$3.35M – 5176
2021
Q2 		$3.35M Buy
+11,188
New +$3.33M ﹤0.01% 2401

Other funds holding RBOT

VS
VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return
AMH
Aspex Management (HK) Central, Hong Kong $6.9B AUM 28.37% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
GCM
Ghisallo Capital Management Boston, Massachusetts $3.63B AUM 30.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CIC
Chase Investment Counsel Charlottesville, Virginia $381M AUM 69.8% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

D.E. Shaw & Co's RBOT Position: Q3 2021 in Review

D.E. Shaw & Co sold out of Vicarious Surgical (RBOT) in Q3 2021, closing a stake of 11,188 shares — an estimated $3.35M sold.

D.E. Shaw & Co first reported a position in RBOT in Q2 2021 and held it in 1 quarter. The position peaked at $3.35M in Q2 2021. 35 funds tracked by Wall St. Rank hold RBOT as of Q3 2021.

  • D.E. Shaw & Co reported no remaining Vicarious Surgical position as of Q3 2021 after selling out during the quarter.
  • D.E. Shaw & Co sold 11,188 Vicarious Surgical shares in Q3 2021, an estimated $3.35M.
  • D.E. Shaw & Co first reported a position in Vicarious Surgical in Q2 2021 and held it in 1 quarter.
  • D.E. Shaw & Co's Vicarious Surgical position peaked at $3.35M in Q2 2021.
  • 35 funds tracked by Wall St. Rank held Vicarious Surgical as of Q3 2021.

Based on D.E. Shaw & Co's 13F filing for Q3 2021, filed 15 Nov 2021.